Simplify Propel Opportunities ETF Rating $14.24 -0.26 (-1.79%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy 2.66Holdings in SURI have an aggregate rating of Moderate Buy based on 112 analyst ratings issued in the past year covering 16 companies (91.3% of the portfolio).SURI Aggregate Price Target$14.24High Prediction$14.24Average Prediction$14.24Low Prediction$14.24Holdings in SURI have an aggregate price target of $14.24 and a range of $14.24 to $14.24 covering 16 companies (91.3% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 16 SURI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings37.76%PAGPPlains GP$18.66-9.6%2.8108 of 5 stars2.40$21.00 12.5%10Analyst DowngradeNews CoveragePositive NewsGap DownHigh Trading Volume8.77%AKROAkero Therapeutics$36.73-8.2%4.0628 of 5 stars3.00$76.29 107.7%9Gap Down7.60%MDGLMadrigal Pharmaceuticals$314.39-3.9%3.4411 of 5 stars2.80$378.44 20.4%10Positive NewsGap Down6.73%CASHPathward Financial$67.53-3.1%3.9449 of 5 stars2.50$90.50 34.0%2Positive News6.31%PHATPhathom Pharmaceuticals$4.88-2.6%3.1737 of 5 stars3.00$22.17 354.2%7Analyst ForecastNews Coverage5.63%RNAAvidity Biosciences$26.57-5.4%2.4824 of 5 stars3.00$66.69 151.0%13Insider TradeGap Down3.37%APLTApplied Therapeutics$0.43+6.0%3.9239 of 5 stars2.50$6.10 1,302.6%6High Trading Volume2.85%ABEOAbeona Therapeutics$4.52-8.7%4.0577 of 5 stars3.00$17.50 287.2%42.64%MISTMilestone Pharmaceuticals$0.70-7.2%1.772 of 5 stars2.50$17.00 2,343.6%4Analyst DowngradeAnalyst RevisionGap DownHigh Trading Volume2.25%SNDXSyndax Pharmaceuticals$11.25-9.7%3.419 of 5 stars2.90$36.20 221.8%10Analyst UpgradeGap Down2.17%DCTHDelcath Systems$11.01-8.3%2.9628 of 5 stars3.00$22.75 106.6%4Positive News2.10%TCRXTScan Therapeutics$1.10-9.1%3.4578 of 5 stars3.00$9.33 748.5%6Short Interest ↓1.32%ZVRAZevra Therapeutics$7.04-5.2%2.6059 of 5 stars3.11$22.29 216.6%9Gap Down0.87%ACHVAchieve Life Sciences$2.18-9.9%1.7015 of 5 stars3.40$15.75 622.5%5Gap DownHigh Trading Volume0.62%ATHAAthira Pharma$0.25-3.8%1.4313 of 5 stars2.00$13.83 5,433.3%40.35%CMPXCompass Therapeutics$1.46-9.0%2.9457 of 5 stars3.11$13.38 816.1%9Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageHigh Trading Volume This page (NYSEARCA:SURI) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SURI Stock Free SURI Stock Alerts